The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Abstract
When exposed to ionizing radiation (IR), eukaryotic cells activate checkpoint pathways to delay the progression of the cell cycle. Defects in the IR-induced S-phase checkpoint cause 'radioresistant DNA synthesis', a phenomenon that has been identified in cancer-prone patients suffering from ataxia-telangiectasia, a disease caused by mutations in the ATM gene. The Cdc25A phosphatase activates the cyclin-dependent kinase 2 (Cdk2) needed for DNA synthesis, but becomes degraded in response to DNA damage or stalled replication. Here we report a functional link between ATM, the checkpoint signalling kinase Chk2/Cds1 (Chk2) and Cdc25A, and implicate this mechanism in controlling the S-phase checkpoint. We show that IR-induced destruction of Cdc25A requires both ATM and the Chk2-mediated phosphorylation of Cdc25A on serine 123. An IR-induced loss of Cdc25A protein prevents dephosphorylation of Cdk2 and leads to a transient blockade of DNA replication. We also show that tumour-associated Chk2 alleles cannot bind or phosphorylate Cdc25A, and that cells expressing these Chk2 alleles, elevated Cdc25A or a Cdk2 mutant unable to undergo inhibitory phosphorylation (Cdk2AF) fail to inhibit DNA synthesis when irradiated. These results support Chk2 as a candidate tumour suppressor, and identify the ATM-Chk2-Cdc25A-Cdk2 pathway as a genomic integrity checkpoint that prevents radioresistant DNA synthesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both Chk1 and Chk2 regulate the functional associations between BRCA1, BRCA2, and Rad51 proteins in response to DNA damage, and thus promote HR-mediated repair of stalled replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [28]
In the citing paper
“Moreover, both the ATR-Chk1 and ATM-Chk2 pathways regulate HR-mediated repair of collapsed replication forks [27, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [28]
In the citing paper
“It has been established that spontaneous HR is promoted by collapsed replication forks that are caused by endogenous DNA SSB [24, 28].”
From NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites (2013) · cites this paper as [28]
Citations
Cites
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
The complexity of p53 modulation: emerging patterns from divergent signalsPreprint
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,315
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y., Matsuoka, S., Wakeham, A. C., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,311
Stewart, G. S., Maser, R. S., Stankovic, T., Bressan, D. A., Kaplan, M. I., Jaspers, N. G. J., Raams, A., Byrd, P. J., Petrini, J. H. J., & Taylor, A. M. R. (1999) · Cell · doi:10.1016/s0092-8674(00)81547-0 · Cited by 1,060
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M. L., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 899
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
A new effector pathway links ATM kinase with the DNA damage response
Demonacos, C., Krstic–Demonacos, M., Smith, L. M., Xu, D., O’Connor, D. P., Jansson, M., & Thangue, N. B. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1170 · Cited by 53
Defending genome integrity during S-phase: putative roles for RecQ helicases and topoisomerase III
Oakley, T. J., & Hickson, I. D. (2002) · DNA repair · doi:10.1016/s1568-7864(02)00002-2 · Cited by 54
Molecular Anatomy of the DNA Damage and Replication Checkpoints
Qin, J., & Li, L. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0139:maotdd]2.0.co;2 · Cited by 52
Cellular Responses to DNA Damage
Wang, J. Y. J., & Ki, S. W. (2002) · Elsevier eBooks · doi:10.1016/b0-12-227555-1/00047-2 · Cited by 52
CHEK2 variants: linking functional impact to cancer risk
Boonen, R. A. C. M., Vreeswijk, M. P. G., & van Attikum, H. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.04.009 · Cited by 54
Chang, H., Chang, M., Wang, H., Huang, G., Lee, Y., Wang, Y., Chan, C., Yeung, S., Tseng, S., & Jeng, J. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.10.006 · Cited by 53
Regulation of the initiation of DNA replication in human cells
Moiseeva, T. N., & Bakkenist, C. J. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.09.003 · Cited by 51
Ku is involved in cell growth, DNA replication and G1-S transition
Rampakakis, E., Paola, D. D., & Zannis‐Hadjopoulos, M. (2008) · Journal of Cell Science · doi:10.1242/jcs.021352 · Cited by 51
Sidorova, J. M., & Breeden, L. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.10.3405-3416.2003 · Cited by 51
Chow, J. P. H., Siu, W. Y., Fung, T. K., Chan, W. M., Lau, A. W. S., Arooz, T., Ng, C.-P., Yamashita, K., & Poon, R. Y. C. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-03-0168 · Cited by 51
Girard, P.-M., Pozzebon, M. E., Delacôte, F., Douki, T., Smirnova, V., & Sage, É. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.05.004 · Cited by 57
PLK-1: Angel or devil for cell cycle progression
Kumar, S., Sharma, A. R., Sharma, G., Chakraborty, C., & Kim, J. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.02.003 · Cited by 50
Differential Mode of Regulation of the Checkpoint Kinases CHK1 and CHK2 by Their Regulatory Domains
Ng, C.-P., Lee, H. C., Ho, C. W., Arooz, T., Siu, W. Y., Lau, A. W. S., & Poon, R. Y. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312215200 · Cited by 52
Chang, W., Hsu, L., Leu, W., Chen, C., & Guh, J. (2015) · Oncotarget · doi:10.18632/oncotarget.5655 · Cited by 49
Cell cycle control, DNA damage checkpoints and cancer
Laiho, M., & Latonen, L. (2003) · Annals of Medicine · doi:10.1080/07853890310014605 · Cited by 51
Loehberg, C. R., Strissel, P. L., Dittrich, R., Strick, R., Dittmer, J., Dittmer, A., Fabry, B., Kalender, W. A., Koch, T., Wachter, D. L., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.11.022 · Cited by 50
Early Events in the DNA Damage Response
Ward, I. M., & Chen, J. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)63001-8 · Cited by 50
Löffler, H., Syljuåsen, R. G., Bártková, J., Worm, J., Lukas, J., & Bártek, J. (2003) · Oncogene · doi:10.1038/sj.onc.1206976 · Cited by 52
Self-citationKim, S. S., Cao, L., Li, C., Xu, X., Huber, L. J., Chodosh, L. A., & Deng, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9498-9507.2004 · Cited by 50
Cdc25A localisation and shuttling: characterisation of sequences mediating nuclear export and import
Källström, H., Lindqvist, A., Pospíšil, V., LUNDGREN, A., & Karlsson, C. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.09.012 · Cited by 50
Jayachandran, G., Ueda, K., Wang, B., Roth, J. A., & Ji, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011994 · Cited by 49
Studying the DNA damage response using in vitro model systems
Garner, E., & Costanzo, V. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.015 · Cited by 47
Matsui, T., Katsuno, Y., Inoue, T., Fujita, F., Joh, T., Niida, H., Murakami, H., Itoh, M., & Nakanishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403232200 · Cited by 47
Radiosensitization in prostate cancer: mechanisms and targets
Palacios, D. A., Miyake, M., & Rosser, C. J. (2013) · BMC Urology · doi:10.1186/1471-2490-13-4 · Cited by 47
Li, C., Andrake, M., Dunbrack, R. L., & Enders, G. H. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01876-08 · Cited by 48
Zhang, M., Qu, J., Gao, Z., Qi, Q., Yin, H., Zhu, L., Wu, Y., Liu, W., Yang, J., & Huang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.601468 · Cited by 47
Regulation and coordination of the different DNA damage responses in Drosophila
Baonza, A., Tur-Gracia, S., Perez-Aguilera, M., & Estella, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.993257 · Cited by 47
Lee, J. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102808 · Cited by 50
Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA Damage
Fernandez, A., Artola, M., Leon, S., Otegui, N., Jimeno, A., Serrano, D., & Calvo, A. (2025) · Cells · doi:10.3390/cells14100748 · Cited by 46
Chiu, H., Huang, W., Liao, T., Wu, H., Munir, M., Shih, W.-L., & Liu, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162356 · Cited by 45
Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system
Delimitsou, A., Fostira, F., Kalfakakou, D., Apostolou, P., Konstantopoulou, I., Κroupis, C., Papavassiliou, A. G., Kleibl, Z., Stratikos, E., Voutsinas, G. E., et al. (2019) · Human Mutation · doi:10.1002/humu.23728 · Cited by 46
Tumor Suppressors and Cell-Cycle Proteins in Lung Cancer
Baldi, A., Luca, A. D., Esposito, V., Campioni, M., Spugnini, E. P., & Citro, G. (2011) · Pathology Research International · doi:10.4061/2011/605042 · Cited by 45
Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites
Fedier, A., Schlamminger, M., Schwarz, V. A., Haller, U., Howell, S. B., & Fink, D. A. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg240 · Cited by 45
DNA Damage Checkpoints and Cancer
Shimada, M., & Nakanishi, M. (2006) · Journal of Molecular Histology · doi:10.1007/s10735-006-9039-4 · Cited by 45
Targeting the Ubiquitin—Proteasome Pathway in Breast Cancer
Cardoso, F., Ross, J. S., Piccart, M. J., Sotiriou, C. P., & Durbecq, V. (2004) · Clinical Breast Cancer · doi:10.3816/cbc.2004.n.020 · Cited by 45
Cdc25A-inhibitory properties and antineoplastic activity of bisperoxovanadium analogues.
Scrivens, P. J., Alaoui‐Jamali, M. A., Giannini, G., Wang, T., Loignon, M., Batist, G., & Sandor, V. A. (2003) · PubMed · Cited by 45
Cao, F., Zhou, T., Simpson, D. A., Zhou, Y., Boyer, J. C., Chen, B., Jin, T., Cordeiro‐Stone, M., & Kaufmann, W. K. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.10.031 · Cited by 45
Meuth, M. (2010) · Cell Division · doi:10.1186/1747-1028-5-21 · Cited by 44
DNA Damage-Induced Cell Cycle Regulation and Function of Novel Chk2 Phosphoresidues
Buscemi, G., Carlessi, L., Zannini, L., Lisanti, S., Fontanella, E., Canevari, S., & Delia, D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00534-06 · Cited by 45
Securin Is a Target of the UV Response Pathway in Mammalian Cells
Romero, F., Gil-Bernabé, A. M., Sáez, C., Japón, M. Á., Pintor‐Toro, J. A., & Tortolero, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2720-2733.2004 · Cited by 44
MiR-365 enhances the radiosensitivity of non-small cell lung cancer cells through targeting CDC25A
Li, H., Jiang, M., Cui, M., Feng, G., Dong, J., Li, Y., Xiao, H., & Fan, S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.03.082 · Cited by 43
Iyer, D., & Rhind, N. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006958 · Cited by 48
Tan, Y. S., Ooi, K. K., Ang, K. P., Akim, A. M., Cheah, Y. K., Halim, S. N. A., Seng, H., & Tiekink, E. R. T. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.06.009 · Cited by 44
Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control
Demidova, A. R., Aau, M. Y., Li, Z., & Yu, Q. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808118200 · Cited by 43
Grigorova, M., Staines, J. M., Özdağ, H., Caldas, C., & Edwards, P. A. (2004) · Cytogenetic and Genome Research · doi:10.1159/000077512 · Cited by 43
Guo, C. Y., Brautigan, D. L., & Larner, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110092200 · Cited by 43
La catastrophe mitotique : un cas particulier d’apoptose
Castedo, M., & Kroemer, G. (2004) · Journal de la Société de Biologie · doi:10.1051/jbio/2004198020097 · Cited by 46
ATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven
Wang, J., Wiltshire, T. D., Wang, Y., Mikell, C., Burks, J., Cunningham, C., Laar, E. S. V., Waters, S. J., Reed, E., & Wang, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400015200 · Cited by 44
Shibata, Y., & Nakamura, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109461200 · Cited by 43
kConFab Investigators, Jekimovs, C., Chen, X., Arnold, J. M., Gatei, M. H., Richard, D. J., Spurdle, A. B., Khanna, K. K., & Chenevix‐Trench, G. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602381 · Cited by 43
TP53, hChk2, and the Li-Fraumeni Syndrome
Varley, J. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-328-3:117 · Cited by 43
ATM and Genome Maintenance: Defining Its Role in Breast Cancer Susceptibility
Khanna, K. K., & Chenevix‐Trench, G. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048772.92326.a1 · Cited by 43
Keaton, M., Bardes, E. S. G., Marquitz, A. R., Freel, C. D., Zyla, T. R., Rudolph, J., & Lew, D. J. (2007) · Current Biology · doi:10.1016/j.cub.2007.05.075 · Cited by 42
Robert, T. E. (2002) · Frontiers in bioscience · doi:10.2741/elder · Cited by 42
Wang, H., Wang, X., Iliakis, G. E., & Wang, Y. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0420:ccnesh]2.0.co;2 · Cited by 42
Design of new anticancer therapies targeting cell cycle checkpoint pathways
Sampath, D., & Plunkett, W. K. (2001) · Current Opinion in Oncology · doi:10.1097/00001622-200111000-00011 · Cited by 42
BRE/BRCC45 regulates CDC25A stability by recruiting USP7 in response to DNA damage.
Biswas, K., Philip, S., Yadav, A., Martin, B. K., Burkett, S., Singh, V., Babbar, A., North, S. L., Chang, S., & Sharan, S. K. (2018) · Nature Communications · doi:10.1038/s41467-018-03020-6 · Cited by 41
Lee, S. S., Vũ, T. T., Weiss, A. S., & Yeo, G. C. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151331 · Cited by 43
Liu, L., Lian-fu, Z., Zuo, J., & Wang, J. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3517 · Cited by 41
CRL Ubiquitin Ligases and DNA Damage Response
Li, J.-M., & Jin, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00029 · Cited by 43
Wang, B., Xu, S., Lu, X., Ma, L., Gao, L., Zhang, S., Li, R., Fu, L., Wang, H., Sun, G., et al. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.113984 · Cited by 41
Induction of Cdc25B Regulates Cell Cycle Resumption after Genotoxic Stress
Bansal, P., & Lazo, J. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3685 · Cited by 43
RING-dependent tumor suppression and G2/M arrest induced by the TRC8 hereditary kidney cancer gene
Brauweiler, A. M., Lorick, K. L., Lee, J. P., Tsai, Y. C., Chan, D., Weissman, A. M., Drabkin, H. A., & Gemmill, R. M. (2006) · Oncogene · doi:10.1038/sj.onc.1210017 · Cited by 41
Hutchins, J. R. A., Dikovskaya, D., & Clarke, P. R. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0061 · Cited by 41
Interactions between radiation and endocrine therapy in breast cancer.
Schmidberger, H., Hermann, R. M., Hess, C. F., & Emons, G. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100375 · Cited by 41
Molecular Pathogenesis of Fanconi Anemia
Taniguchi, T., & D’Andrea, A. D. (2002) · International Journal of Hematology · doi:10.1007/bf02982016 · Cited by 42
Meningioma protein-protein interaction network.
Zali, H., & Rezaei–Tavirani, M. (2014) · PubMed · Cited by 40
Epigenetic based synthetic lethal strategies in human cancers
Gao, A., & Guo, M. (2020) · Biomarker Research · doi:10.1186/s40364-020-00224-1 · Cited by 40
Kastan, M. B. (2001) · Nature · doi:10.1038/35071218 · Cited by 40
Nayak, D., Kumar, A., Chakraborty, S., Rasool, R. U., Amin, H., Katoch, A., Gopinath, V., Mahajan, V., Zilla, M. K., Rah, B., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.70 · Cited by 40
Wang, H., Wang, X., Zhou, X.-Y., Chen, D. J., Li, G. C., Iliakis, G. E., & Wang, Y. (2002) · PubMed · Cited by 40
Höglund, A., Strömvall, K., Li, Y., Forshell, L. P., & Nilsson, J. A. (2011) · Cell Cycle · doi:10.4161/cc.10.20.17887 · Cited by 39
Invasive oral cancer stem cells display resistance to ionising radiation
Gemenetzidis, E., Gammon, L., Biddle, A., Emich, H., & Mackenzie, I. C. (2015) · Oncotarget · doi:10.18632/oncotarget.6268 · Cited by 39
Tichý, A., Vávrová, J., Pejchal, J., & Řezáčová, M. (2010) · Acta Medica (Hradec Kralove Czech Republic) · doi:10.14712/18059694.2016.57 · Cited by 42
Characterization ofCHEK2 mutations in prostate cancer
Wu, X., Dong, X., Liu, W., & Chen, J. (2006) · Human Mutation · doi:10.1002/humu.20321 · Cited by 41
Domagała, P., Wokołorczyk, D., Cybulski, C., Huzarski, T., Lubiński, J., & Domagała, W. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1635-7 · Cited by 38
Regulation of the Embryonic Cell Cycle During Mammalian Preimplantation Development
Palmer, N., & Kaldis, P. (2016) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2016.05.001 · Cited by 38
Targeted gene repair activates Chk1 and Chk2 and stalls replication in corrected cells
Ferrara, L., & Kmiec, E. B. (2006) · DNA repair · doi:10.1016/j.dnarep.2005.11.009 · Cited by 39
Defective ATM‐p53–mediated apoptotic pathway in multiple sclerosis
Deng, X., Ljunggren‐Rose, A., Maas, K. H., & Sriram, S. (2005) · Annals of Neurology · doi:10.1002/ana.20600 · Cited by 38
CHEK2-Positive Breast Cancers in Young Polish Women
Cybulski, C., Górski, B., Huzarski, T., Byrski, T., Gronwald, J., Dębniak, T., Wokołorczyk, D., Jakubowska, A., Kowalska, E., Oszurek, O., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0158 · Cited by 39
ATM regulates a DNA damage response posttranscriptional RNA operon in lymphocytes
Mazan-Mamczarz, K., Hagner, P. R., Zhang, Y., Dai, B., Lehrmann, E., Becker, K. G., Keene, J. D., Gorospe, M., Liu, Z., & Gartenhaus, R. B. (2011) · Blood · doi:10.1182/blood-2010-09-310987 · Cited by 39
Weber, A. M., Drobnitzky, N., Devery, A., Bokobza, S., Adams, R., Maughan, T., & Ryan, A. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11845 · Cited by 39
Shibata, A., & Jeggo, P. A. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1564083 · Cited by 37
Mice with the CHEK2 *1100delC SNP are predisposed to cancer with a strong gender bias
Bahassi, E. M., Robbins, S. B., Yin, M., Boivin, G. P., Kuiper, R., STEEG, H. V., & Stambrook, P. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909237106 · Cited by 38
Linking cell division to cell growth in a spatiotemporal model of the cell cycle
Yang, L., Han, Z., MacLellan, W. R., Weiss, J. N., & Qu, Z. (2006) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.11.020 · Cited by 37
Response to DNA damage: why do we need to focus on protein phosphatases?
Shimada, M., & Nakanishi, M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00008 · Cited by 38
Şahin, İ. H., Iacobuzio–Donahue, C. A., & O'Reilly, E. M. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1094057 · Cited by 39
Degradation of p12 Subunit by CRL4Cdt2 E3 Ligase Inhibits Fork Progression after DNA Damage
Terai, K., Shibata, E., Abbas, T., & Dutta, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.505586 · Cited by 36
Germline genome protection: implications for gamete quality and germ cell tumorigenesis
Bloom, J. C., Loehr, A. R., Schimenti, J. C., & Weiss, R. S. (2019) · Andrology · doi:10.1111/andr.12651 · Cited by 38
Lethal and Non-Lethal Functions of Caspases in the DNA Damage Response
Lopez, K. E., & Bouchier‐Hayes, L. (2022) · Cells · doi:10.3390/cells11121887 · Cited by 38
Zhang, Y., Rohde, L. H., Emami, K., Hammond, D. K., Casey, R. C., Mehta, S. K., Jeevarajan, A. S., Pierson, D. L., & Wu, H. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.07.009 · Cited by 36
Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications
Oberle, C., & Blattner, C. (2010) · Current Genomics · doi:10.2174/138920210791110979 · Cited by 37
Germline mutations in the CHEK2 kinase gene are associated with an increased risk of bladder cancer
Złowocka, E., Cybulski, C., Górski, B., Dębniak, T., Słojewski, M., Wokołorczyk, D., Serrano‐Fernández, P., Trubicka, J., van de Wetering, T., Sikorski, A., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23099 · Cited by 36
Antimycin A as a mitochondria damage agent induces an S phase arrest of the cell cycle in HeLa cells
Han, Y. H., Kim, S. H., Kim, S. Z., & Park, W. H. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.06.023 · Cited by 36
The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target
Alao, J. P. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902835475 · Cited by 36
Meyer, A. A., Dörk, T., Sohn, C., Karstens, J. H., & Bremer, M. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.12.002 · Cited by 36
DUSP6 regulates drug sensitivity by modulating DNA damage response
Bagnyukova, T., Restifo, D., Beeharry, N., Gabitova, L., Li, T., Serebriiskii, I. G., Golemis, E. A., & Astsaturov, I. A. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.353 · Cited by 38
Titanium dioxide nanoparticles activate the ATM-Chk2 DNA damage response in human dermal fibroblasts
Prasad, R. Y., Chastain, P. D., Nikolaishvili‐Feinberg, N., Smeester, L., Kaufmann, W. K., & Fry, R. C. (2012) · Nanotoxicology · doi:10.3109/17435390.2012.710659 · Cited by 36
Kaczmarek-Ryś, M., Ziemnicka, K., Hryhorowicz, S., Górczak, K., Hoppe-Gołębiewska, J., Skrzypczak-Zielińska, M., Tomys, M., Gołąb, M., Szkudlarek, M., Budny, B., et al. (2015) · Hereditary Cancer in Clinical Practice · doi:10.1186/s13053-015-0030-5 · Cited by 36
Neumann, J., Boerries, M., Köhler, R., Giaisi, M., Krammer, P. H., Busch, H. S., & Li‐Weber, M. (2013) · International Journal of Cancer · doi:10.1002/ijc.28521 · Cited by 36
Metadata
- Authors
- Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J.
- Affiliations
- Danish Cancer Society (DK)
- Venue
- Nature
- Published
- 2001-04
- Volume
- 410
- Issue
- 6830
- Pages
- 842-847
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1480741751
- Cited by
- 1,085
- References
- 30
- Citations by year
- 2026: 14 · 2025: 11 · 2024: 22 · 2023: 20 · 2022: 24 · 2021: 29 · 2020: 19 · 2019: 31 · 2018: 24 · 2017: 30 · 2016: 40 · 2015: 30 · 2014: 37 · 2013: 43 · 2012: 55
- FWCI
- 29.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute on Aging
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Keywords
- radioresistant DNA synthesis, ATM, Chk2, CDC25A, CDK2, S-phase checkpoint, ionizing radiation, DNA damage response, tumour suppressor, ataxia telangiectasia, DNA replication inhibition, protein phosphorylation
- MeSH terms
- Alleles, Animals, Cell Cycle, Cell Line, DNA Replication, DNA-Binding Proteins, Humans, Phosphorylation, Protein Kinases, Radiation Tolerance, Radiation, Ionizing, Serine, Transfection, Signal Transduction, S Phase, Protein Serine-Threonine Kinases, Cell Cycle Proteins, cdc25 Phosphatases, Tumor Suppressor Proteins, Mice, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review